Fertility and Sterility
Volume 90, Issue 5 , Pages 2016.e7-2016.e10 , November 2008

Pregnancy in a hermaphrodite with a male-predominant mosaic karyotype

Received 5 January 2008 ,Revised 25 January 2008 ,Accepted 31 January 2008.

References 

  1. Tanaka Y, Fujiwara K, Yamauchi H, Mikami Y, Kohno I. Pregnancy in a woman with a Y chromosome after removal of an ovarian dysgerminoma. Gynecol Oncol. 2000;79:519–521
  2. Talerman A, Verp MS, Senekjian E, Gilewski T, Vogelzang N. True hermaphrodite with bilateral ovotestis, bilateral gonadoblastomas and dysgerminomas, 46,XX/46,XY karyotype, and a successful pregnancy. Cancer. 1990;66:2668–2672
  3. Starceski PJ, Sieber WK, Lee PA. Fertility in true hermaphroditism. Adolesc Pediatr Gynecol. 1988;1:55–56
  4. Minowada S, Fukutani K, Hara M, Shinohara M, Kamioka J, Isurugi K, et al. Childbirth in a true hermaphrodite. Eur Urol. 1984;10:414–415
  5. Tiltman AJ, Sweerts M. Multiparity in a covert true hermaphrodite. Obstet Gynecol. 1982;60:752–754
  6. Williamson HO, Phansey SA, Mathur RS. True hermaphrodite with term vaginal delivery and a review. Am J Obstet Gynecol. 1981;141:262–265
  7. Tegenkamp TR, Brazzell JW, Tegenkamp I, Labidi F. Pregnancy without benefit of reconstructive surgery in a bisexually active true hermaphrodite. Am J Obstet Gynecol. 1979;135:427–428
  8. Kim MH, Gumpel JA, Graff P. Pregnancy in a true hermaphrodite. Obstet Gynecol. 1979;53(3 Suppl):40S–42S
  9. Mayou BJ, Armon P, Lindenbaum RH. Pregnancy and childbirth in a true hermaphrodite following reconstructive surgery. Br J Obstet Gynaecol. 1978;85:314–316
  10. Narita O, Manba S, Nakanishi T, Ishizuka N. Pregnancy and childbirth in a true hermaphrodite. Obstet Gynecol. 1975;45:593–595
  11. Verp MS, Harrison H, Ober C, Oiveru D, Amarose AP, Lindgren V, et al. Chimerism as the etiology of a 46XX/46XY fertile true hermaphrodite. Fertil Steril. 1992;57:346–349
  12. Kim KR, Kwon Y, Joung JY, Kim KS, Ayala AG, Ro JY. True hermaphroditism and mixed gonadal dysgenesis in young children: a clinicopathologic study of 10 cases. Mod Pathol. 2002;15:1013–1018

 S.A.S. has nothing to disclose. S.E.L. has nothing to disclose. P.S. has nothing to disclose. M.G.M. is a consultant for Ethicon Women's Health, Covidien, Gynesonics, Karl Storz Endoscopy, and AMAG Pharmaceuticals and is a shareholder in Gynesonics and Impres Medical. S.K. has nothing to disclose.

PII: S0015-0282(08)00233-1

doi: 10.1016/j.fertnstert.2008.01.104

Fertility and Sterility
Volume 90, Issue 5 , Pages 2016.e7-2016.e10 , November 2008

Article Tools

* Image Usage & Resolution